SAMN06468140
External Id
Bayer Pharma AG
INSDC center name
2017-09-30T00:00:00Z
INSDC first public
SRS2017442
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
SRS2017442
SRA accession
CHL-1
http://www.ebi.ac.uk/efo/EFO_0002132
cell line
anti-H3K27Ac (Diagenode, C15410174)
chip antibody
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
melanoma cancer cell line CHL-1
source_name
skin
http://purl.obolibrary.org/obo/UBERON_0000014
tissue
CHL1_H3K27Acq_02_DMSO
title
melanoma
http://www.ebi.ac.uk/efo/EFO_0000756
tumor type